Form D — Mati Therapeutics Inc.
0001574251-26-000001 · filed 2026-07-02
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $4,896,500
- Total sold
- $2,649,815
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Mati Therapeutics Inc.
- CIK
- 1574251
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 101 Colorado Street
AUSTIN, TX 78701 - Phone
- 512-720-1333
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert Butchofsky · Executive OfficerAustin, TX Find on LinkedIn ↗
-
Christopher Muller · Executive OfficerAustin, TX Find on LinkedIn ↗
-
Joseph Tortorice III · DirectorAustin, TX Find on LinkedIn ↗
-
Cameron Nelson · Executive OfficerAustin, TX Find on LinkedIn ↗
-
Peter McDonnell · DirectorAustin, TX Find on LinkedIn ↗
-
Ken Jones · DirectorAustin, TX Find on LinkedIn ↗
-
Jim Mazzo · DirectorAustin, TX Find on LinkedIn ↗
-
Dave Fellows · DirectorAustin, TX Find on LinkedIn ↗
-
Linda Lupini · DirectorAustin, TX Find on LinkedIn ↗
View original on SEC EDGAR.